en

PRODUCT DETAIL

Dasatinib Sandoz 20 mg

Code 9822C
MA number 44/0392/18-S
Product Form: tbl flm 60x20 mg (fľ.HDPE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Sandoz Pharmaceuticals d.d., Slovenia
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
L01EA02 Dasatinib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 12.12.2018
SPC: SPC_Dasatinib Sandoz 20 mg_09.2023.pdf  
PIL: PIL_Dasatinib Sandoz 20 mg_09.2023.pdf  
Safety feature Yes
Data update: 06.09.2023
eu-flag.png sk-flag.png